<DOC>
	<DOCNO>NCT00693069</DOCNO>
	<brief_summary>Adequate platelet inhibition percutaneous coronary intervention ( PCI ) reduce peri-procedural long-term ischemic complication . Documented reduce response clopidogrel associate subsequent major adverse cardiovascular event . Strategies optimize platelet inhibition pre-PCI investigation . This study seek evaluate effect platelet aggregation four different dose regimen clopidogrel give elective PCI .</brief_summary>
	<brief_title>Effect Different Dosing Regimens Clopidogrel Before Elective Percutaneous Coronary Intervention ( PCI ) Platelet Function</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Adult patient indication elective coronary angiography without PCI major hemorrhagic diathesis active bleed acute myocardial infarction ( MI ) within 14 day enrolment unstable angina STsegment change &gt; 1 mm least two contiguous electrocardiographic lead rest troponin I level &gt; 0.06 microg/L within 14 day enrolment stroke within past 3 month platelet count &lt; 100 x 10 9/L prothrombin time &gt; 1.5 time control hematocrit &lt; 25 % hemoglobin level &lt; 100 g/L alcohol drug abuse enrolment investigational drug trial within previous month use thienopyridines , glycoprotein ( GP ) IIb/IIIa inhibitor , warfarin acenocoumarol within previous week allergic reaction contraindication clopidogrel aspirin administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>angioplasty</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>platelet</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
</DOC>